Clearside Biomedical Inc
Major Drugs - Alpharetta, GA, US
Clearside Biomedical Inc Employees
Clearside Biomedical Inc Senior Management
Clearside Biomedical Inc Details
Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). Clearside's SCS injection platform, utilizing the Company's proprietary SCS Microinjector®, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector and strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. Clearside's first product, XIPERE™ (triamcinolone acetonide injectable suspension) for suprachoroidal use, was approved by the U.S. Food and Drug Administration in October 2021. For more information, please visit www.clearsidebio.com.
Clearside Biomedical Inc Technologies
Email Providers
Outlook
Load Balancers
Ubuntu
CMS
WP Engine
Hosting
Google Cloud Hosting
Search Marketing
Adobe Marketing Cloud